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Abstract
Mutations that cause a reduction in protein kinase A (PKA) activity have been shown to extend lifespan in yeast. Loss of
function of mammalian RIIb, a regulatory subunit of PKA expressed in brain and adipose tissue, results in mice that are lean
and insulin sensitive. It was therefore hypothesized that RIIB null (RIIb
2/2) mice would express anti-aging phenotypes. We
conducted lifespan studies using 40 mutant and 40 wild type (WT) littermates of equal gender numbers and found that
both the median and maximum lifespans were significantly increased in mutant males compared to WT littermates. The
median lifespan was increased from 884 days to 1005 days (p=0.006 as determined by the log rank test) and the 80%
lifespan (defined here as 80% deaths) was increased from 941 days to 1073 days (p=0.004 as determined by the Wang-
Allison test). There was no difference in either median or 80% lifespan in female genotypes. WT mice of both genders
became increasingly obese with age, while mutant mice maintained their lean phenotype into old age. Adiposity was found
to correlate with lifespan for males only. 50% of male mice between 30 and 35 g, corresponding to about 5% body fat, for
either genotype lived over 1000 days. No male mouse outside of this weight range achieved this lifespan. During their last
month of life, WT mice began losing weight (a total of 8% and 15% of body weight was lost for males and females,
respectively), but RIIb
2/2 male mice maintained their lean body mass to end of life. This attenuation of decline was not seen
in female mutant mice. Old male mutant mice were insulin sensitive throughout their life. Both genders showed modestly
lower blood glucose levels in old mutants compared to WT. Male mutants were also resistant to age-induced fatty liver.
Pathological assessment of tissues from end of life male mutant mice showed a decrease in tumor incidence, decreased
severity of renal lesions, and a trend towards a decrease in age-related cardiac pathology. These findings help establish the
highly conserved nature of PKA and suggest that disruption of PKA affects physiological mechanisms known to be
associated with healthy aging.
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Introduction
cAMP-dependent protein kinase A (PKA) is the best character-
ized kinase member of the protein kinase superfamily. It mediates
signal transduction and transcription for many cellular processes,
and plays a major role in the control of triglyceride storage and
metabolism in response to nutrient status. PKA activity is triggered
by G protein-coupled receptors in response to numerous
neurotransmitters and hormones, and is mediated by increasing
intracellular cAMP levels through the modulation of adenylyl
cyclase (AC) activity [1]. Studies in yeast have shown the AC/PKA
pathway to be of importance to longevity. Loss of function of
CYR1, an AC ortholog, extends lifespan [2]. Reducing activity of
the yeast adenylate cyclase CDC35, the GTP-GDP exchange
factor CDC25, or the PKA catalytic subunits TPK1, TPK2 and
TPK3, results in lengthened life span [3]. Inhibition of the cAMP-
PKA pathway in yeast genetically mimics caloric restriction (CR),
the only non-genetic intervention known to increase lifespan in a
wide range of organisms from yeast to mice [3]. The effect of down
regulation of the AC/PKA pathway on aging and age-related
disease in mammals has not been extensively studied [4]. In this
regard, it is of interest that disruption of the AC isoform type 5
adenylyl cyclase (AC5) in mice was reported to increase lifespan
and resistance to cardiac stress in mice [5]. However, little is
known about the age-related effects of deleting specific PKA
subunit genes.
Mammalian PKA consists of two regulatory and two catalytic
subunits [1]. In the mouse, there are four regulatory and two
catalytic isoforms, each encoded by a separate gene [6]. RIIb
(MGI:97760) is one of the regulatory isoforms and is predomi-
nantly expressed in brown and white adipose tissue and in brain
[1,7], tissues known to be important in the regulation of energy
homeostasis. Nearly all PKA activity in adipose tissue and 50% of
PKA activity in the striatum, hypothalamus, and cortex is
attributed to the RIIb subunit [7]. Partial compensation for the
loss of RIIb occurs in these tissues with up-regulation of the RI
regulatory subunit [8–10]. RIIb null (RIIb
2/2) mice are lean in
comparison to their wild type littermates, have increased resting
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(UCP1) concentrations, and lipid hydrolysis [7]. Loss of the RIIb
subunit has been shown to protect mice on a high-fat, high-
carbohydrate diet against weight gain, hyperinsulinemia, fatty
livers and insulin resistance, reduce plasma levels of VLDL and
LDL cholesterol, and improve glucose dispersal [6]. Lower serum
glucose and cholesterol levels and improved insulin sensitivity are
known to occur during caloric restriction [11,12].
We therefore hypothesized that old RIIb
2/2 mice would be
characterized by anti-aging phenotypes based on data showing
that disruption of PKA extends lifespan in yeast, as well as the
anti-obesity and anti-diabetic phenotypes of these mice. Our
preliminary findings help establish the highly conserved nature of
PKA and suggest that disruption of PKA affects physiological
mechanisms known to be associated with healthy aging.
Results
PKA RIIb null mice are long-lived
We show that both the median and 80% lifespans (age at which
80% of cohort is dead) are significantly increased in PKA RIIb
mutant males (Figure 1A) (P=0.006 for the log rank median
lifespan test and p=0.004 for the Wang-Allison 80% lifespan test)
but not RIIb mutant females (Figure 1B). Note that the P-values
take into account the small sample size; e.g. there is only a 0.6%
chance that this difference would have been seen in the
experiment even with only 20 mice if there is no underlying
difference. Also note that the difference in male mice is significant
even after adjustment for multiple testing of all mice and then the
sex subsets (P=0.02 and P=0.012, respectively). Therefore, these
mice fulfill the prediction for delayed aging based on extended
lifespans in yeast with loss of function of PKA gene homologs.
Adiposity correlates with lifespan for male mice
At 2 to 5 months of age, both male and female mutants had
body weights approximately 10% less than those of WT littermates
(data not shown). By 19 to 20 months of age, both male and female
WT littermates were approximately 25% heavier than the
respective RIIb mutant mice (Figure 2A,B). When old (18 month)
mice were examined, it was found that for both genders and
genotypes, body weight was directly proportional to percentage
body fat (Figure 2C,D). Therefore, RIIb mutants are resistant to
age-related obesity. It was also found that 16 month-old WT, male
mice incurred 10-fold higher levels of serum leptin than young (2
month-old) WT mice, while RIIb
2/2 littermates maintained low
leptin levels with age (Figure 2E). Serum leptin levels in
heterozygous RIIb
+/2 females did not appear to rise as
dramatically with age and therefore attenuation in the mutants
was not as marked (data not shown), although there was not a
sufficient sample size for statistical analysis.
Body weight, which we found to correspond directly to % body
fat, correlated with lifespan in WT mice for males, but not females
(Figure 3A,C). Most RIIB
2/2 male mice had maximal body
weights between 30 and 35 g (Figure 3B). About half of the
mutants within this weight range lived over 1000 days. The two
mutants below 30 g had shortened lifespans of less than 700 days,
as did the one mutant that had a maximal body weight above
35 g. Of the male, WT cohort, only 4 mice had maximal body
weights within this weight range, and 2 of them lived beyond 1000
days - the longest lifespans in this cohort. Female RIIb
2/2 mice all
had maximal body weights between 20 and 30 g, and did not
appear to have an optimal body weight for extended lifespan
(Figure 3D).
Absence of PKA RIIb protects mice from fatty liver, insulin
resistance, age-related hyperinsulinemia, and cardiac
dysfunction
Livers were dissected out of 18 month-old, male mice (5 WT
and 6 RIIb
2/2). It was found that with age, WT mice developed
livers up to twice the size of a younger WT liver (Figure 4A). Livers
of RIIb
2/2 mice weighed on average approximately 25% less
than those of WT mice and were darker in color (Figure 4B,C).
QNMR analysis revealed a direct correlation between the weight
of the liver and its % fat content (Figure 4D).
Blood glucose levels for 24-month-old PKA RIIb mutant males
and females were significantly lower than respective WT
littermates (p#0.01) (Figure 5A). However, levels for genotypes
of both sexes fell within an acceptable normal range between 100
and 115 mg/dl. Therefore, blood glucose levels are not likely
directly associated with extended lifespan. Serum insulin levels for
male, WT mice increased 4-fold with age, while RIIB
2/2
littermates maintained low serum insulin levels between 2 and
Figure 1. A. Disruption of the RIIb subunit of Protein Kinase A
increases lifespan in male mice on the C57BL/6 background. A.
Both the median and maximum lifespans were significantly increased in
mutant males compared to WT littermates. The median lifespan was
increased from 884 days to 1005 days (p=0.006 as determined by the
log rank test) and the maximum lifespan (defined here as 80% deaths)
was increased from 941 days to 1073 days (p=0.004 as determined by
the Wang-Allison test). B. There was no difference in either median or
maximum lifespan in female genotypes.
doi:10.1371/journal.pone.0005963.g001
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RIIb
+/2 females did not appear to rise as dramatically with age
and therefore attenuation in the mutants was not as marked (data
not shown). We injected insulin into a separate cohort of young (2
to 5 month) and old (18 month) RIIb mutant males and WT
littermates. Both age groups of mutant mice were more insulin
sensitive than WT littermates (p#0.05) (Figures 5C and D)
suggesting an association with lower blood glucose levels in males.
Young (2 to 5 month) females were also tested, and no differences
were found between genotypes (data not shown).
We chose to use echocardiography to evaluate cardiac function
because we can see evidence of dysfunction as early as 15 months of
age in C57BL/6 wild type mice, which continually progresses with
increasing age (Dai et al., 2009). In a cross-sectional cohort of six
malemicepergenotypeat24monthsofage,RIIbmutantmicewere
significantly protected from age-related left ventricular (LV)
hypertrophy compared with WT littermates (p,0.001, Fig. 6A).
Because of the size differences, we standardized all measurements to
tibial length. RIIb
2/2 mice also showed a trend toward better both
Ea/Aa ratios and myocardial performance indices compared to WT
littermates (6B).
PKARIIb
2/2femalesbutnotmalesloseweightduringoldage
When weights of individual mice at 19 to 20 months of age were
compared to measurements taken during the last month of life,
WT males showed an average loss of several grams, while RIIb
mutant littermates maintained their weight (p#0.05) (Figure 7A).
This phenomenon was not observed in females, for which both
genotypes lost weight during the measurement period
(Figure 4B). This observation may be directly related to
extended lifespan in males but not females, or may be an
indirect consequence of other age-related conditions in these
mice. Both genotypes eat about the same amount, so the body
composition differences cannot be attributed to differences in
food intake.
Absence of PKA RIIb protects mice from age-related
pathology
Pathological evaluation was limited because tissues from a
number of mice found dead were not suitable for histological
fixation. This did provide increased confidence that the end of life
end point had been attained, but the relatively low starting cohort
numbers (20 per genotype per gender) precluded extensive
histopathological assessment. Tissues, collected from old mice
that were euthanized because they were determined to die within
several hours, were immediately fixed in 10% buffered formalin,
stained with hematoxylin/eosin and read by a board certified
veterinary pathologist with expertise in mouse pathology (P.
Treuting). Evaluations were done on tissues from 6 mutant and 6
WT males at end of life. We were able to determine significant
Figure 2. RIIb
2/2 mice are resistant to age-related obesity. A,B. RIIb
2/2 mice maintain lower body weights than WT littermates. Body weights
for RIIb
2/2 and WT littermates were measured weekly beginning at 19 to 24 months of age. Measurements were started with 15 mice per gender per
genotype. Measurements taken in the last month of each individual mouse’s life were not included. Each point represents a mean. Error bars
represent standard deviations. N#15 (sample size decreased with time). b=borderline significance; *P,0.05; **P,0.001; ***P,0.0001 (as determined
by Student’s t-test). C,D. Body weight and body fat are directly proportional. Body weight and percentage body fat were measured in both old (18
month old) males and females (8 WT and 9 RIIb
2/2 males; 3 heterozygous RIIb
+/2 and 2 RIIb
2/2 females) and found to be directly proportional for
both genders (R
2=0.9774 and 0.6182, respectively). E. Old RIIb
2/2 mice are resistant to age-induced increases in serum leptin. Serum leptin for
young (2 month) and old (16 month) male, RIIB
2/2 and WT littermates (5 WT and 4 RIIb
2/2; and 8 WT and 9 RIIb
2/2, respectively). Data presents as
means. Error bars represent standard deviations. **P,0.001.
doi:10.1371/journal.pone.0005963.g002
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types of graded renal lesions. Tubular degeneration and both
interstitial and pelvic inflammation showed significantly better
scores in RIIb
2/2 males compared to WT (Figure 8A,B). Liver
and spleen were examined for tumor incidence and %
involvement. No tumor differences were seen in liver (data not
shown), but tumors in the spleen were seen in all of the WT mice
and in only about 40% of mutant mice (Figure 8C). Heart tissue
from 18 month-old mice (5 WT and 6 RIIb
2/2) was also
examined. While different types of heart lesions from both
genotypes were mild on average, it was found that there was a
trend for the mutants to have better scores. The differences,
however, were not significant (Figure 8D). Looking at hearts from
higher numbers of, or of older mice with more severe lesions,
might yield more significant differences. These observations
suggest that absence of PKA RIIb suppresses tumor incidence
and other age-related pathology.
Discussion
We have shown that disruption of PKA RIIb in mice extends
lifespan and protects against age-related obesity, weight loss at end
of life, cardiac hypertrophy, incidence and severity of age-related
pathology, and insulin resistance. Although the mechanisms for
the extended lifespan are not yet known, the fact that it is observed
only in males provides a uinique paradigm for further investigation
of this interesting gene pathway. In this regard, we show
preliminary evidence to suggest that the lifespan phenotype seen
in the absence of RIIb is directly associated with decreased body
fat but not insulin sensitivity. We also show that RIIb null males
have less age-related fatty liver, cardiac hypertrophy, cancer and
renal pathology.
During maturity, many of the WT mice of both genders showed
a gradual but significant increase in body weight, found to be
associated with an increase in fat mass. Long-lived RIIb
2/2 males
weighed less, and had less body fat than their WT littermates. In
contrast, there was no correlation between adiposity and lifespan
in RIIb
2/2 females. Gender-related phenotypic differences have
been found in other long-lived mouse models such as the Ames
dwarf mouse which shows a greater lifespan increase in females
[13]. Sexual dimorphism of lifespan extension is also seen in flies
[14,15]. Such differences are believed to be the consequence of
interplay between the mutated pathways and hormones or other
growth factors which have sex-specific secretion patterns [16,17].
There are sex differences in the incidence and presentation of most
diseases [18]. In mice, sex differences are mediated by sex
chromosome-encoded proteins as well as gonadal steroids [19].
The majority of sexually dimorphic traits are the result of sex
differences in expression of the same gene [20], thousands of
which, in adipose tissue, show sexual dimorphism [21]. A study by
Nas et al., 2009 [22], looked for sex-specific gene coexpression
networks in mice and found strong body fat and lipid correlations
with a sex-specific module in adipose tissue. This is not surprising,
since adipose tissue is an endocrine-responsive organ that interacts
with sex hormones [22]. Interestingly, genes in this module are
known to be involved in metabolism and obesity, and include
Figure 3. Adiposity correlates with lifespan for males only. A, C. When lifespan of WT mice was plotted against their maximal body weight, a
correlation was found for males, but not females (N=13 and 15, and R
2=0.4795 and 0.0369, respectively). Males with the longest lifespans (over 1000
days) had body weights between 30 and 35 g. B. Most (82%) of the RIIb
2/2 male mice examined had body weights between 30 and 35 g. 50% of
these mice lived over 1000 days, and the 3 mice that fell outside of this weight range had shortened lifespans of under 700 days (Total N=17). D. Of
the 20 female RIIb
2/2 mice measured, only 4 lived to 1000 days or higher. All 5 mice with maximal body weights below 24 g had shortened lifespans
equal to or under 800 days, as did the one mouse above 35 g, but lifespans for mice falling between these two body weights were variable.
doi:10.1371/journal.pone.0005963.g003
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2/2 male mice have attenuated age-related fatty livers. A. Old (18 month old) WT mice developed livers that were twice
the size of, and paler in color than livers from young mice. B,C. Livers from 18 month-old RIIb
2/2 littermates were smaller, darker in color, and 25%
lower in weight than those from their WT littermates. N=5 (WT) and 6 (RIIb
2/2). D. Liver weight correlated directly with % fat content (R
2=0.7064)
N=4 (WT) and 6 (RIIb
2/2). For both C and D: Numbers represent means. Error bars represent standard deviations. P’s determined by Student’s t-test.
doi:10.1371/journal.pone.0005963.g004
Figure 5. Both young and old RIIb
2/2 male mice are insulin sensitive compared to WT, and RIIb
2/2 males are resistant to age-
induced hyperinsulinemia. A. RIIb
2/2 blood glucose levels were slightly lower than WT for both old males and females, but both genotypes of
both genders fell into an acceptable range. N=15. B. Male WT mice experienced over 4-fold increases in serum insulin levels with age, while RIIb
2/2
littermates maintained low serum insulin levels between 2 and 16 months of age. 2 month-old mice: N=5 (WT) and 4 (RIIb
2/2). 16 month-old mice:
N=8 (WT) and 9 (RIIb
2/2). C,D. Blood glucose levels of both 2 to 5 month (C) and 18 month (D) RIIb
2/2 males dropped more rapidly and further in
response to an inter-peritoneal insulin injection. N=6; points represent means. Results were standardized by setting initial blood glucose levels at
100%. Data for all figures: Numbers represent means, and error bars represent standard deviations. **P,0.001; *P,0.05 and b represents borderline
significance (as determined by Student’s t-test).
doi:10.1371/journal.pone.0005963.g005
Disruption of PKA in Mice
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[22]. As WT mice age and accumulate increased fat stores,
differences in expression of these genes between genders may
explain differences in both the susceptibility of males and females
to different diseases, as well as to their phenotypic response to a
lack of the RIIb subunit.
Another factor which may contribute to the observed gender
specificity of the longevity phenotype is differences in fat
distribution between genders. Less important to health than
overall adiposity is the type of fat. Sex differences in body fat
distribution are well recognized, with males storing more fat in the
visceral area than females [23]. Increases in visceral adiposity are a
common feature of aging, and in humans are associated with both
diabetes and mortality from cardiovascular disease [24–28].
Removal of the visceral fat pad from old, insulin resistant rats
restores their peripheral and hepatic insulin action to the levels of
young rats, and decreases the expression of tumor necrosis factor-a
and leptin in subcutaneous adipose tissue [29]. While our study
showed increased adiposity in both old male and female WT mice,
and attenuation by the RIIb mutation in both genders, we only
looked at overall adiposity. Fat distribution in RIIb
2/2 mutants
remains to be investigated.
Not surprisingly, given their reduced adiposity, old RIIb
2/2
mice were found to have lower serum levels of leptin than WT
mice. In humans, plasma leptin levels, which increase with obesity,
are a predictor of heart disease, stroke and cardiovascular
mortality in males only [30–35]. In mice, studies looking at the
role of lifespan regulation are contradictory. Harper et al., 2003
[36], observed a negative effect of high levels of serum leptin on
lifespan. However, in the long-lived fat cell-specific insulin
receptor knockout mouse, lifespan extension occurs in the
presence of an increase in plasma leptin. These mice still have a
reduced fat mass, as well as low levels of insulin, and this data has
been interpreted to mean that insulin levels are a more critical
factor in prolonging life in mammals than leptin [37,38]. It is
unknown at this point whether the lower serum leptin levels in
RIIb
2/2 mice play a role in their longevity, or are merely an
indirect result of their reduced adiposity.
RIIb
2/2 males showed a decrease in liver fat that paralleled
body weight and hence also correlated with lifespan. Hepatic
adiposity is related to obesity. Male RIIb
2/2 mice were found to
be resistant to age-associated fatty livers. Non-alcoholic fatty liver
disease (NAFLD) encompasses a spectrum of liver disease from
steatosis to cirrhosis and is defined by the American Association
Figure 6. Old RIIb
2/2 male mice have attenuated cardiac dysfunction. A. RIIb
2/2 mice were significantly protected from age-related LV
hypertrophy, shown by lower LV mass normalized to tibia length in 24 month old WT and RIIb
2/2 mice. B. These RIIb
2/2 mice also had superior Ea/
Aa ratios and myocardial performance indices (MPI) compared to WT littermates. N=6. Numbers represent means. Error bars represent standard
deviations. P’s determined by Student’s t-test.
doi:10.1371/journal.pone.0005963.g006
Figure 7. RIIB
2/2 male mice do not lose weight during aging. Weights of individuals were compared between the first body weight
measurements at 19 to 24 months of age and the final measurements taken during the last month of life. WT mice showed an average loss of several
grams during senescence (A,B) while male RIIb
2/2 littermates maintained their body weight (A). This phenomenon was not seen in RIIb
2/2 females
(B). Data presented as means. Error bars represent standard deviations. N=15. *P,0.05 (as determined by Student’s t-test).
doi:10.1371/journal.pone.0005963.g007
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2/2 male mice show attenuated renal dysfunction, tumor incidence, and a trend towards attenuated cardiac
pathology. A. Old RIIb
2/2 male mice showed attenuated tubular degeneration and interstitial and pelvic inflammation compared to wild-type
littermates although renal lesions in both genotypes was relatively mild. N=6. Numbers represent means. Error bars represent standard deviations.
*P,0.05 (determined by Student’s t-test). B. Hematoxylin and eosin-stained section of kidneys from WT and RIIb
2/2 male mice. The WT mouse had mild
perivascular and interstitial lymphohistiocytic accumulations (severity score 2) and mild tubular changes including attenuated epithelium and
intralumenal proteinaceous material (arrow). This mouse also had marked neutrophilic pyleitis that likely contributed to moribundity. In contrast, the
RIIb
2/2 mouse had minimal interstitial inflammation (severity score 1) surrounding a small caliper tangentially sectioned vessel (arrows). Original
magnification for bothimages, 20X. C.Spleensfrom100%of WT mice but only 40% ofRIIb
2/2 mice examined atend oflife, presented withlesions.N=6.
D. Hearts from old (18 month) RIIb
2/2 male mice tended towards better scores than WT for 4 of 6 types of lesions graded, although differences were not
significant. IR=interstitial fibrosis, cytomeg=cytomegaly, inflamm=inflammation, arteriosc=arteriosclerosis. N=5 (WT) and 6 (RIIb
2/2). Numbers
represent means. Error bars represent standard deviations. Numbers above columns represent probability values, determined by Student’s t-test.
doi:10.1371/journal.pone.0005963.g008
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exceeding 5% to 10% by weight [39]. Fatty livers are related to
obesity, perhaps due to adipokines released from adipose tissue, or
to exposure of the liver to free fatty acids released from adominal
adipose tissue [40]. We found that the fat content of livers of our
male mice was directly proportional to their % body fat. It has also
been found that parental longevity may be associated with
decreased NAFLD in humans, and that this association is even
stronger in men [41]. The increased association of fatty liver with
lifespan in males points to protection from fatty liver as a possible
physiological mechanism for the extended lifespan seen in RIIb
2/
2 males.
Studies on different long-lived mouse models suggest that the
role of insulin in longevity is complex. Mutants such as the Ames
and Snell dwarf mice show both extended lifespan as well as
increased insulin sensitivity [42,43]. However, several reports have
shown increased lifespan in relatively insulin resistant mouse lines
such as IRS-1 and IRS-2 [44,45], while the fat specific insulin
receptor knock out mouse (FIRKO) has reduced insulin-stimulated
glucose uptake in adipose tissue but increased systemic insulin
sensitivity [37,38]. Male RIIb
2/2 mice were found to be insulin
sensitive compared to WT mice, regardless of age. It is, however,
unlikely that the increase in lifespan of male RIIb
2/2 mice bears
any relation to their increased insulin sensitivity, as we did not find
differences in insulin sensitivity between young and old WT mice,
and the modestly lower blood glucose levels found in the mutants
did not show gender specificity. Therefore, while RIIb
2/2 mice
may have enjoyed health benefits due to chronic insulin sensitivity
over the course of their lifespan, insulin sensitivity in old RIIb
2/2
mice did not reflect attenuation of an age-related dysfunction, and
the insulin sensitivity seen in the male mutants is probably not the
cause of their extended lifespan. Interestingly, while the insulin
resistance test did not show significant differences between young
and old either WT or RIIb
2/2 mice, and while neither genotype
became hyperglycemic with age, old WT mice did develop
hyperinsulinemia. While the attenuation of age-induced obesity in
RIIb
2/2 mutants does not seem to promote longevity and
healthful aging by its effects on peripheral or systemic action of
insulin on glucose homeostasis, it may do so by a reduction in
insulin-related intracellular signaling through the IGF-1 pathway.
It is well documented in human studies that aging is
accompanied by slow progressive and irreversible structural
changes and functional declines in the heart. Echocardiography
in healthy populations from the Framingham Study and Baltimore
Longitudinal Study on Aging showed an age-dependent increase
in the prevalence of left ventricular hypertrophy, decline in
diastolic function, and relatively preserved systolic function at rest
but a decline in exercise capacity, as well as an increase in the
prevalence of atrial fibrillation (reviewed in [46]). Diastolic heart
failure, defined as symptoms of heart failure in the setting of
diminished diastolic function, is pervasive in older individuals and
markedly increases the risk of mortality [47]. We have previously
shown that the mouse recapitulates human cardiac aging by
performing non-invasive echocardiographic measurements on WT
and mitochondrial-targeted catalase transgenic mice over the
course of their lifespans [48]. Echocardiographic parameters were
found to show progressive and highly reproducible changes with
advancing mouse age. These changes parallel those of human
aging, particularly left ventricular mass. We found that old (24
month) male RIIb
2/2 mice had attenuated age-related cardiac
hypertrophy as well as better myocardial performance indices and
Ea/Aa ratios. These data are in agreement with cardiac sparing in
adenylyl cyclase (AC5) null mice, which demonstrate an
upregulation of both the Raf/MEK/ERK signaling pathway
and cell protective molecules such as superoxide dismutase [5].
Like RIIb, AC is a component of the PKA signaling pathway, and
like RIIb
2/2 mice, AC5 null mice are long-lived, suggesting an
association of the PKA pathway with cardiac protection and
extended lifespan.
Advanced stages of aging are associated with loss of weight in
contrast to the increase in weight seen from adolescence through
adulthood. Unlike WT mice, RIIb
2/2 males, but not females,
maintained their weight during their last month of life. Loss of
weight culminating in death commonly occurs in mammals at
advanced stages and is a hallmark of a geriatric syndrome termed
‘failure to thrive’ [49]. Common diseases associated with failure to
thrive are cancer, chronic lung disease, chronic renal insufficiency,
liver disease, diabetes, and congestive heart failure [50], and a
reduction in any of these age-related diseases may be a
contributing factor to the longevity seen in RIIb
2/2 males.
Another cause of weight loss in advanced age is sarcopenia, or loss
of skeletal muscle mass and strength, due to a number of factors
including loss of motoneurons, decreased physical activity, altered
hormonal status, and decreased food intake [51–55]. The lack of
weight loss in RIIb
2/2 males may be due to an attenuation of
sarcopenia, which would represent another aspect of improved
healthy aging in these mutants.
The decreased incidence and severity of histopathological
lesions in tissues from RIIb are consistent with the increased
lifespan phenotype. However, the small numbers examined
histologically at end of life preclude more definitive conclusions
about what causes of death were attenuated in the male mice.
There were histopathological differences between genotypes that
indicated a reduction in age-related kidney dysfunction. Also of
interest was the decrease in incidence of lymphosarcoma, which
very well may be associated with increased lifespan since this is the
most predominant form of cancer in C57BL/6 mice [56]. In
contrast to what we see in RIIb mice, we have reported that long-
lived mitochondrially targeted catalase transgenic mice [57] do not
suppress lymphosarcoma but do attenuate epithelial cancers [56].
Therefore, different mechanisms are likely involved.
In conclusion, while RIIb
2/2 male mice show many
indications of attenuated aging, it is still unknown exactly why
they live longer. Certainly, the direct association of lifespan with
suppressed adiposity is of interest for further study. The genes
encoding PKA subunits are conserved from yeast to man, and
their disruption has been shown to extend longevity in both yeast
[3] and now in mice. Although the yeast TPK genes are PKA
catalytic subunit genes, and not regulatory subunit genes like
RIIb,l o s so fR I I b in mice causes a concomitant and
compensatory decrease in catalytic subunits [7,8], providing a
mechanistic link with loss of function of TPK and extended
lifespan in yeast, and loss of function of RIIb and extended
lifespan in mice. That disruption of PKA genes confer extended
lifespan in such divergent species suggests a highly conserved role
for PKA in longevity, and makes subunits of PKA promising
pharmaceutical targets for the treatment of age and obesity-
related diseases in humans.
Materials and Methods
Animals
The generation and genotyping of RIIb
2/2 mutant mice has
been described previously [7]. The line is maintained on the
C57BL/6 background after more than 10 backcrosses. RIIb
2/2
and WT littermate mice used in this study were generated from
heterozygote breeding pairs so that age and gender could be
equally matched.
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Mice were assigned to cohorts at the time of weaning based on
genotype and gender. Mice of both genders on the C57BL/6
background were allowed to live to the end of their natural life. All
mice were maintained in the same specific pathogen free housing
environment and fed a standard rodent chow ad lib, with no
difference in food intake between any of the genotypes. They were
housed in gender-specific groups of three to five in individually
ventilated cages (Allentown, PA). The housing environment was a
specific pathogen free barrier facility, and the room kept at a
constant temperature of 22 degrees C, with a 12-hr light/dark
cycle. Sentinel animal screening consisted of quarterly testing for
infectious bacterial, viral and parasitic pathogens, with all tests
being negative throughout the study. The ad libitum fed chow
(PicoLab Rodent Diet 20) consisted of 20% protein, 5% fat, and
53% carbohydrate. All mice had access to automatically-
delivered, reverse osmosis-treated water. Mice were examined
daily until their natural death, defined as being found dead in their
cage or being unresponsive to touch and euthanized. Kaplan-Meir
survival curves were constructed using the known date of birth and
date of death for each mouse. The log-rank test was then used to
determine statistical differences between cohorts. Maximum
lifespan is defined as the mean age of the oldest 20% of mice
from each genotype and gender. A total of 20 mice per genotype
per gender (80 total) was used to asses survival, with no mice
remaining alive at the end of the study. All procedures were
performed with the approval of the University of Washington
Institutional Animal Care and Use Committee.
Body weights, serum leptin and QMR
Body weights were measured weekly beginning at 19 to 24
months of age and until end of life. Body weights of an additional
cohort of 18 month-old male mice (5 WT and 6 RIIb
2/2) were
also measured, and their body composition analyzed in vivo using
quantitative magnetic resonance (QMR) methods (Echo Medical
Systems, Houston, TX). For QMR measurements, conscious
rodents were placed in the sample holder and the sample holder
then inserted into the center of the magnetic resonance machine.
Each animal underwent 3 replicate measurements. The measure-
ment procedure itself causes no harm to the animal. Serum leptin
was measured for the following male, WT and RIIb
2/2
littermates: 2 month-old (5 WT and 4 RIIb
2/2) and 16 month-
old (8 WT and 9 RIIb
2/2) and the following female WT and
RIIb
2/2 littermates: 2 month-old (6 WT and 3 RIIb
2/2) and 16
month-old (3 heterozygous RIIb
+/2 and 2 RIIb
2/2). For serum
leptin measurements, food was removed from mice 12 h before
the collection of blood from the retro-orbital sinus into serum
separator tubes (365956; Becton Dickinson, Franklin Lakes, NJ);
after separation, plasma was either used immediately or stored at
280uC until analysis. Plasma leptin was measured using an ELISA
kit (EZML-82K; LINCO, St. Charles, MO) as per manufacturer’s
instructions.
Liver composition
Liver composition analyses were performed on 18 month-old,
male mice (5 WT and 6 RIIb
2/2 littermates). Mice were
euthanized by CO2, and livers were dissected out and weighed.
A small (approximately 30 mg) piece of the large lobe was set aside
for QNMR composition measurements. Composition measure-
ments were measured using quantitative nuclear magnetic
resonance imaging (QNMR), with a EchoMRI
TM 3-in-1 Animal
Tissue Composition Analyzer, at the University of Washington
Mouse Metabolic Phenotyping Center (MMPC).
Blood glucose, serum insulin and insulin sensitivity
Blood glucose was measured on the same day as the initial body
weights on all mice from the lifespan cohort at 19 to 24 months of
age. For blood glucose measurements, food was removed from
mice 6 h before blood was drawn by tail pricking. Analyses were
performed using a glucometer and Comfort Curve test strips
(Advantage; Accu-Chek, Roche, Basel, Switzerland). Serum
insulin was measured for the following male, WT and RIIb
2/2
littermates: 2 month-old (5 WT and 4 RIIb
2/2) and 16 month-old
(8 WT and 9 RIIb
2/2) and the following female WT and RIIb
2/
2 littermates: 2 month-old (6 WT and 3 RIIb
2/2) and 16 month-
old (3 heterozygous RIIb
+/2 and 2 RIIb
2/2). For serum insulin
measurements, food was removed from mice 12 h before the
collection of blood from the retro-orbital sinus into serum
separator tubes (365956; Becton Dickinson, Franklin Lakes, NJ);
after separation, plasma was either used immediately or stored at
280uC until analysis. Plasma insulin was measured using an
ELISA kit (EZRMI-13K; LINCO, St. Charles, MO) as per
manufacturer’s instructions. Insulin resistance assays were per-
formed on additional cohorts of 6 mice per genotype, for young (2
to 5 month) and old (18 month) males and young (2 to 5 month)
females. For insulin resistance assays, mice were first fasted
overnight for 16 hours. Mice were then injected intraperitoneally
with human insulin (Humulin R; Eli Lilly, Indianapolis, IN)
diluted with sterile diluent (Eli Lilly, Indianapolis, IN) at a dose of
1.0 units insulin/kg body wt for the insulin resistance assay. Blood
glucose measurements were performed as previously described, at
0, 30, 60 and 90 minutes after injection.
Echocardiography
Male mice 24 months of age were used for non-invasive
echocardiography. Six mice of each genotype (WT and RIIb
2/2)
were analyzed. The mice were anesthetized by placing them in a
flow-through system containing 3–4% isoflurane in a 100%
oxygen mix. Following loss of consciousness, the mice were placed
on a modified mask assembly that allowed a continuous flow of 1–
2% isoflurane in an oxygen mix. The mice could breathe
spontaneously, and the depth of anesthesia was monitored by
continuous recording of heart rate. Heart rates were not allowed to
fall below 400 (near physiological). The mice were taped to an
isothermal pad that maintained their body temperature at 37uC.
EKG and heart rate were monitored throughout the imaging
procedure. Heart rate was determined from a surface electrocar-
diogram. From a transthoracic approach, two-dimensional
targeted M-mode echocardiographic recordings were obtained.
Histochemistry
End of life (EOL) mice were processed for histochemical
analyses. Selected tissues collected at necropsy were fixed in 10%
phosphate buffered formalin and processed routinely, sectioned at
4 um and examined by a board-certified veterinary pathologist
(PT) blinded to mouse genotype. Morphological diagnoses were
assigned for all tissues examined with detailed histopathological
evaluation of the kidney and contributing causes of moribundity/
death (COD) were assigned as described (56). Renal lesions were
scored on a 0–4 severity scale (as described in [56]). Briefly, the
renal lesions graded included membranous, proliferative or
membranoproliferative glomerulonephropathy, interstitial fibrosis
and inflammation, tubular regeneration, degeneration and
necrosis, perivascular or peripelvic lymphoid aggregates, pyleitis
and mineralization. Non-neoplastic diseases of moderate or severe
degree were assigned as contributing to the animal’s demise and
neoplastic processes were considered if organs were effaced by
neoplasia so that function would be altered. Hearts from 18-
Disruption of PKA in Mice
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2/2) male mice were also examined
as described above. Cardiac lesions were graded on a severity scale
from 0–4 and were examined for interstitial fibrosis, cytomegaly,
inflammation, mineralization, valvular changes, arteriosclerosis
and amyloidosis [56].
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